Correlation Between Enveric Biosciences and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enveric Biosciences and InMed Pharmaceuticals, you can compare the effects of market volatilities on Enveric Biosciences and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and InMed Pharmaceuticals.
Diversification Opportunities for Enveric Biosciences and InMed Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enveric and InMed is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enveric Biosciences and InMed Pharmaceuticals
Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the InMed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Enveric Biosciences is 1.74 times less risky than InMed Pharmaceuticals. The stock trades about -0.53 of its potential returns per unit of risk. The InMed Pharmaceuticals is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest 586.00 in InMed Pharmaceuticals on August 31, 2024 and sell it today you would lose (156.00) from holding InMed Pharmaceuticals or give up 26.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enveric Biosciences vs. InMed Pharmaceuticals
Performance |
| Timeline |
| Enveric Biosciences |
| InMed Pharmaceuticals |
Enveric Biosciences and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enveric Biosciences and InMed Pharmaceuticals
The main advantage of trading using opposite Enveric Biosciences and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
| InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |